Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma

por Chang, Xiubao, Xu, Qinqin, Hou, Yuexian, Li, Cynthia, Xu, Ye, Stewart, A. Keith
Publicado 2017

Systolic dysfunction associated with carfilzomib use in patients with multiple myeloma

por Jain, Tania, Narayanasamy, Hemalatha, Mikhael, Joseph, Reeder, Craig B., Bergsagel, P. Leif, Mayo, Angela, Stewart, A. Keith, Mookadam, Farouk, Fonseca, Rafael
Publicado 2017

Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted Treatment

por Cerchione, Claudio, Usmani, Saad Z., Stewart, A. Keith, Kaiser, Martin, Rasche, Leo, Kortüm, Martin, Mateos, María-Victoria, Spencer, Andrew, Sonneveld, Pieter, Anderson, Kenneth C.
Publicado 2022

The SH3–SAM Adaptor HACS1 is Up-regulated in B Cell Activation Signaling Cascades

por Zhu, Yuan Xiao, Benn, Sally, Li, Zhi Hua, Wei, Ellen, Masih-Khan, Esther, Trieu, Young, Bali, Meenakshi, McGlade, C. Jane, Claudio, Jaime O., Stewart, A. Keith
Publicado 2004

Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms

por Gagnon, Marie-France, Tian, Shulan, Geyer, Susan, Sharma, Neeraj, Vachon, Celine M., Kusne, Yael, Bergsagel, P. Leif, Stewart, A. Keith, Rajkumar, S. Vincent, Kumar, Shaji, Ailawadhi, Sikander, Baughn, Linda B.
Publicado 2022

Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4

por Zhu, Yuan Xiao, Shi, Chang-Xin, Bruins, Laura A., Wang, Xuewei, Riggs, Daniel L., Porter, Brooke, Ahmann, Jonathan M., de Campos, Cecilia Bonolo, Braggio, Esteban, Bergsagel, P. Leif, Stewart, A. Keith
Publicado 2019

Transcriptional profiles define drug refractory disease in myeloma

por Zhu, Yuan Xiao, Bruins, Laura A., Chen, Xianfeng, Shi, Chang‐Xin, Bonolo De Campos, Cecilia, Meurice, Nathalie, Wang, Xuewei, Ahmann, Greg J., Ramsower, Colleen A., Braggio, Esteban, Rimsza, Lisa M., Stewart, A. Keith
Publicado 2022

Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma

por Bansal, Radhika, Baksh, Mizba, Larsen, Jeremy T., Hathcock, Matthew A., Dingli, David, Stewart, A. Keith, Kapoor, Prashant, Kourelis, Taxiarchis, Hayman, Suzanne R., Warsame, Rahma M., Fonseca, Rafael, Bergsagel, P. Leif, Ailawadhi, Sikander, Kumar, Shaji K., Lin, Yi
Publicado 2023

Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance

por Kumar, Shaji K., Berdeja, Jesus G., Niesvizky, Ruben, Lonial, Sagar, Laubach, Jacob P., Hamadani, Mehdi, Stewart, A. Keith, Hari, Parameswaran, Roy, Vivek, Vescio, Robert, Kaufman, Jonathan L., Berg, Deborah, Liao, Eileen, Rajkumar, S. Vincent, Richardson, Paul G.
Publicado 2019

Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients

por Fonseca, Rodrigo, Arribas, Mariano, Wiedmeier-Nutor, Julia E., Kusne, Yael N., González Vélez, Miguel, Kosiorek, Heidi E., Butterfield, Richard (Duke) J., Kirsch, Ilan R., Mikhael, Joseph R., Stewart, A. Keith, Reeder, Craig, Larsen, Jeremy, Bergsagel, P. Leif, Fonseca, Rafael
Publicado 2023

Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients

por Fonseca, Rodrigo, Arribas, Mariano, Wiedmeier-Nutor, Julia E., Kusne, Yael N., González Vélez, Miguel, Kosiorek, Heidi E., Butterfield, Richard (Duke) J., Kirsch, Ilan R., Mikhael, Joseph R., Stewart, A. Keith, Reeder, Craig, Larsen, Jeremy, Bergsagel, P. Leif, Fonseca, Rafael
Publicado 2023

Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells

por Kumar, Harish, Mazumder, Suman, Sharma, Neeraj, Chakravarti, Sayak, Long, Mark D., Meurice, Nathalie, Petit, Joachim, Liu, Song, Chesi, Marta, Sanyal, Sabyasachi, Stewart, A. Keith, Kumar, Shaji, Bergsagel, Leif, Rajkumar, S. Vincent, Baughn, Linda B., Van Ness, Brian G., Mitra, Amit Kumar
Publicado 2022

Cyclophosphamide, bortezomib and dexamethasone (CyBorD) induction for newly diagnosed multiple myeloma: High response rates in a phase II clinical trial

por Reeder, Craig B., Reece, Donna E., Kukreti, Vishal, Chen, Christine, Trudel, Suzanne, Hentz, Joseph, Noble, Brie, Pirooz, Nicholas A., Spong, Jacy E., Piza, Jesus G., Zepeda, Victor H. Jimenez, Mikhael, Joseph R., Leis, Jose F., Bergsagel, P. Leif, Fonseca, Rafael, Stewart, A. Keith
Publicado 2009

Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma

por Lazzari, Elisa, Mondala, Phoebe K., Santos, Nathaniel Delos, Miller, Amber C., Pineda, Gabriel, Jiang, Qingfei, Leu, Heather, Ali, Shawn A., Ganesan, Anusha-Preethi, Wu, Christina N., Costello, Caitlin, Minden, Mark, Chiaramonte, Raffaella, Stewart, A.  Keith, Crews, Leslie A., Jamieson, Catriona H. M.
Publicado 2017

Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry

por Baughn, Linda B., Pearce, Kathryn, Larson, Dirk, Polley, Mei-Yin, Elhaik, Eran, Baird, Michael, Colby, Colin, Benson, Joanne, Li, Zhuo, Asmann, Yan, Therneau, Terry, Cerhan, James R., Vachon, Celine M., Stewart, A. Keith, Bergsagel, P. Leif, Dispenzieri, Angela, Kumar, Shaji, Rajkumar, S. Vincent
Publicado 2018

Phase 2 trial of Intravenously Administered Plerixafor for Stem Cell Mobilization in Patients with Multiple Myeloma Following Lenalidomide Based Initial Therapy

por Kumar, Shaji K., Mikhael, Joseph, LaPlant, Betsy, Lacy, Martha Q., Buadi, Francis K., Dingli, David, Gertz, Morie A., Laumann, Kristina, Miceli, Teresa, Mahlman, Marcia, Bergsagel, Leif P., Hayman, Suzanne R., Reeder, Craig, Stewart, A. Keith, Dispenzieri, Angela, Gastineau, Dennis A., Winters, Jeffrey L
Publicado 2013

Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study

por Dimopoulos, Meletios A., Stewart, A. Keith, Masszi, Tamás, Špička, Ivan, Oriol, Albert, Hájek, Roman, Rosiñol, Laura, Siegel, David, Mihaylov, Georgi G., Goranova‐Marinova, Vesselina, Rajnics, Péter, Suvorov, Aleksandr, Niesvizky, Ruben, Jakubowiak, Andrzej, San‐Miguel, Jesus, Ludwig, Heinz, Palumbo, Antonio, Obreja, Mihaela, Aggarwal, Sanjay, Moreau, Philippe
Publicado 2017

Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19

por Berlin, Alejandro, Lovas, Mike, Truong, Tran, Melwani, Sheena, Liu, Justin, Liu, Zhihui Amy, Badzynski, Adam, Carpenter, Mary Beth, Virtanen, Carl, Morley, Lyndon, Bhattacharyya, Onil, Escaf, Marnie, Moody, Lesley, Goldfarb, Avi, Brzozowski, Luke, Cafazzo, Joseph, Chua, Melvin L. K., Stewart, A. Keith, Krzyzanowska, Monika K.
Publicado 2021

Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study

por Uson, Pedro L. S., Samadder, N. Jewel, Riegert-Johnson, Douglas, Boardman, Lisa, Borad, Mitesh J., Ahn, Daniel, Sonbol, Mohamad B., Faigel, Douglas O., Fukami, Norio, Pannala, Rahul, Kunze, Katie, Golafshar, Michael, Klint, Margaret, Esplin, Edward D., Nussbaum, Robert L., Stewart, A. Keith, Bekaii-Saab, Tanios
Publicado 2021

Multidisciplinary Model to Implement Pharmacogenomics at the Point of Care

por Caraballo, Pedro J., Hodge, Lucy S., Bielinski, Suzette J., Stewart, A. Keith, Farrugia, Gianrico, Schultz, Cloann G., Rohrer-Vitek, Carolyn R., Olson, Janet E., St. Sauver, Jennifer L., Roger, Veronique L., Parkulo, Mark A., Kullo, Iftikhar J., Nicholson, Wayne T., Elliott, Michelle A., Black, John L., Weinshilboum, Richard M.
Publicado 2016